CIRB Studies
Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.
To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.
| Study Number | Lead Group | Study Title | CIRB | Study Status |
|---|---|---|---|---|
| URCC-21038 | NCORP-University of Rochester Cancer Center | Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 Immunotherapy in a Community Oncology Setting | Cancer Prevention and Control CIRB | Available to Open |
| URCC-22053 | NCORP-University of Rochester Cancer Center | High-dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients | Cancer Prevention and Control CIRB | Available to Open |
| URCC-22063 | NCORP-University of Rochester Cancer Center | LOTUS-CC: Longitudinal Observational Trial to Uncover Subtypes of Cancer Cachexia | Cancer Prevention and Control CIRB | Available to Open |
| URCC-23086CD | NCORP-University of Rochester Cancer Center | Sexual Orientation and Gender Identity Data Collection in Community Oncology Practice | Cancer Prevention and Control CIRB | Available to Open |
| UWI20-00-01 | CP-CTNet_CLO-University of Wisconsin | A Phase II Trial of the Immunogenicity of a DNA Plasmid Based Vaccine (STEMVAC) Encoding Th1 Selective Epitopes from Five Antigens Associated With Breast Cancer Stem Cells (MDM2, YB1, SOX2, CDH3, CD105) in Participants with Early Stage Triple Negative Breast Cancer | Cancer Prevention and Control CIRB | Available to Open |
| UWI20-04-01 | CP-CTNet_CLO-University of Wisconsin | A Dose Escalation Phase I Trial of the Safety and Immunogenicity of RG1-VLP, a Candidate Broadly Protective Vaccine for the Prevention of HPV-Associated Cancer | Cancer Prevention and Control CIRB | Available to Open |
| UWI2014-03-01 | CP-CTNet_CLO-University of Wisconsin | A Phase I Trial of the Safety and Immunogenicity of a DNA Plasmid Based Vaccine (WOKVAC) Encoding Epitopes Derived from Three Breast Cancer Antigens (IGFBP-2, HER2, AND IGF-1R) in Patients with Breast Cancer | Cancer Prevention and Control CIRB | Available to Open |
| UWI2015-05-01 | CP-CTNet_CLO-University of Wisconsin | Phase Ib 9cUAB30 in Early Stage Breast Cancer to Evaluate Biologic Effect | Cancer Prevention and Control CIRB | Available to Open |
| UWI2016-07-01 | CP-CTNet_CLO-University of Wisconsin | Phase IIB Randomized, Placebo-Controlled Trial of ACTOplus met® XR in Subjects with Stage I-IV Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Prior to Definitive Treatment | Cancer Prevention and Control CIRB | Completed |
| UWI2016-08-01 | CP-CTNet_CLO-University of Wisconsin | Pilot Study of Daily Exemestane in Women with Complex Atypical Hyperplasia of the Endometrium / Endometrial Intraepithelial Neoplasia or Grade 1 Endometrial Cancer | Cancer Prevention and Control CIRB | Available to Open |